CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2020 ◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):